Preliminary Trial Shows Israeli Technology May Make Inoperable Pancreatic Tumors Resectable

Early-stage clinical trial findings suggest a new Israeli cancer technology could enable surgery for previously inoperable pancreatic tumors. UCI Health, one of two U.S. centers in the study, reported that four of six treated patients subsequently underwent surgery, with three showing no cancer cells at surgical margins. These are preliminary results focused on safety and dosage, and do not yet establish effectiveness, requiring further confirmation in larger studies.